Dallas Covid trials is a subsidiary of Southwest Family Medicine Research center.
We are excited to present our latest COVID-19 study: A study to treat COVID-19 positive individuals to help stop this pandemic.
Treating acute COVID-19 infection with a monoclonal antibody given as intramuscular injection.
Age: ≥ 18 years old
Laboratory-confirmed SARS-CoV-2 infection (by PCR; antigen or nucleic acid from any respiratory tract specimen) OR signs/symptoms of COVID 19 present within 6 days.
No history or current hospitalization for COVID-19.
Patients meeting enrollment requirements will be compensated for time a travel.
Patient qualifies if:
They have not been vaccinated with a COVID-19 vaccine.
Age is ≥ 18 years.
Have had COVID-19 symptoms for the past 7 days or has a Lab confirmed SARS-CoV2 test (by PCR, Antigen, or Nucleic acid from any respiratory sample).
No History of Hospitalization due to COVID-19 or previous COVID-19 infection.